Zimmer Biomet
370
26
73
167
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
22.7%
84 terminated/withdrawn out of 370 trials
66.5%
-20.0% vs industry average
6%
24 trials in Phase 3/4
56%
93 of 167 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (370)
Persona IQ Cohort Study
Role: lead
Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System
Role: lead
MDR - Comprehensive Primary Revision Stems PMCF
Role: lead
Zimmer Biomet Shoulder Arthroplasty PMCF
Role: lead
Cemented vs Cementless Persona Keel RCT
Role: lead
PMCF Study on the Safety, Performance and Clinical Benefits Data of the XtraFix® Small External Fixation System
Role: lead
OsseoFit Stemless Shoulder System (Anatomic)
Role: lead
Persona Partial Knee Clinical Outcomes Study
Role: lead
Comprehensive Nano - Post Market Clinical Follow-Up Study
Role: lead
SCP Hip Outcomes Study
Role: lead
Persona SoluTion PPS Femur PMCF
Role: lead
Zimmer Biomet-RibFix Titan
Role: lead
A Longitudinal Outcomes Study of the Subchondroplasty® Procedure in the Foot/Ankle
Role: lead
ROSA Knee Intraoperative Planning Flexibility Study
Role: lead
MDR Vivacit-E Elevated Study
Role: lead
Anatomical Shoulder Domelock System Study
Role: lead
A Prospective Multicenter Longitudinal Cohort Study of the Mymobility Platform
Role: lead
MDR - PMCF Study for RingLoc Bipolar Acetabular Cup and Endo II Femoral Heads
Role: lead
PMCF Study on the Safety, Performance and Clinical Benefits Data of the Zimmer® Reconstruction System
Role: lead
Persona Total Knee Arthroplasty Outcomes Study
Role: lead